Blood Journals Portfolio/X
Jul 15, 2025, 07:37
Triple Therapy Breakthrough: Corticosteroids, IVIG, and Platelet Transfusions Transform Management of Critical ITP Bleeding – Blood Journals Portfolio
The Blood Journals Portfolio reported on its official X։
“The combination of corticosteroids, IV immunoglobulin, and platelet transfusion was the most common treatment for critical ITP bleeding.”

This recent report underscores the critical role of combination therapy—corticosteroids, IV immunoglobulin, and platelet transfusion—in effectively managing severe bleeding episodes in immune thrombocytopenia (ITP). It highlights the importance of timely, comprehensive treatment approaches to significantly improve patient outcomes in life-threatening situations.
For more detailed insights on this and other hemostasis topics, visit Hemostasis Today.
American Journal of Hematology
American Society of Hematology
American Thrombosis and Hemostasis Network
ASH
Bleeding management
Blood Journals Portfolio
Corticosteroids
Critical ITP Bleeding
Emergency hematology treatment
Hemostasis therapy
Hemostasis Today
Immune thrombocytopenia
Intravenous Immunoglobulin (IVIG)
ISTH
ITP Treatment
Platelet disorders
Platelet transfusion
Triple Therapy
-
Apr 22, 2026, 17:19Ralf Ludwig: Bridging Population Data and Immunology in Inflammatory Diseases
-
Apr 22, 2026, 17:15Giacomo Rossi: Genetic Study Reveals 10 Genes in Hyperemesis Gravidarum
-
Apr 22, 2026, 17:06Maura Boerio: Quantifying Barriers to Care in Vascular Ehlers-Danlos Syndrome
-
Apr 22, 2026, 17:05Kausik Ray։ Metabolically Healthy Obesity Is Being Re-Evaluated as a High-Risk Condition Needing Closer Attention
-
Apr 22, 2026, 16:58Baba-Jallah Epega: Sickle Cell Resilience Through Patient Voices and Clinical Insight
-
Apr 22, 2026, 16:44Francisco Chacón-Lozsán: Cytokine Storm Is Not Just Inflammation, It Is Organ Failure in Motion
-
Apr 22, 2026, 16:29CBTH 2026 Opens with First Workshop in Germany – European Hematology Association
-
Apr 22, 2026, 16:16Christopher Pittman: Superficial Venous Disease Needs Arterial-Level Follow-Up
-
Apr 22, 2026, 15:47Mohammed Alo: Being Fit Does Not Protect You from High LDL